Fas/Fas-L signalling system plays an important role in immune homeostasis (Nagata, 1997) . Fas-L (also termed as CD95L, APO-1L) is a member of the tumour necrosis factor receptor superfamily and may trigger a death signal into Fas-bearing cells after engagement with Fas molecule (Itoh et al, 1991; Takahashi et al, 1994) . Contrast to a well-regulated manner in lymphocytes (Alderson et al, 1995; Van Parijs and Abbas, 1996) , Fas-L is constitutively expressed in several non-lymphoid tissues as well as in tumours of various origins. The expression of functional Fas-L on some tumour cells may confer them the ability to kill T cells in vitro (Hahne et al, 1996; Strand et al, 1996; Walker et al, 1998) . These findings led to an assumption that Fas-L might contribute to immune privilege of tumours. However, using Fas-L-positive cells for organ transplantation or ectopic expression of Fas-L in transgenic animals revealed that Fas-L could also enhance immune destruction of Fas-L-positive cells (Chervonsky et al, 1997; Seino et al, 1997) . Under certain growth conditions, cross-linking of Fas transmits signal for proliferation instead of death signal in tumours as well as in immune cells (Alderson et al, 1993 , Owen-Schaub et al, 1994 . More complicatedly, a reverse signalling of Fas-L has been reported in cytotoxic lymphocytes, where Fas-L augmented cell proliferation following its ligation (Suzuki and Fink, 1998) .
Glioma cells express Fas-L and induce apoptosis in Fasexpressing cell lines ex vivo (Gratas et al, 1997; Saas et al, 1997; Yang et al, 2000) . While, glioma cells can also express Fas and are susceptible to Fas-L-triggered death indicating that a subtle balance of growth and death signals exists in vivo (Weller et al, 1994; Yang et al, 1999) . Conversely, endogenous Fas/Fas-L interaction in glioma cells could provide signal driving cell cycle progression in glioma cells probably through the MEK-ERK pathway (Shinohara et al, 2000) . In this study, we constructed a Fas-L-specific hammerhead ribozyme (Fas-L ribozyme ), placed upstream of enhanced green fluorescent protein (EGFP) gene to suppress the Fas-L expression in human glioma cells. Ribozyme catalyses endoribonucleolytic cleavage of substrate RNA in trans with a sequence-specific manner (Birikh et al, 1997; Poeschla and Wong-Staal, 1997) and has been exploited to inhibit genes such as fos, ras and fas-L (Scanlon et al, 1991; Du et al, 1996; Chang et al, 1997) . Our Fas-L ribozyme recognizes the Fas-L transcript at site coding for the extracellular domain of Fas-L. After transfection into glioma cells, Fas-L ribozyme inhibited the expression of Fas-L at both mRNA and protein levels. Stable transfectants of glioma cells carrying Fas-L ribozyme were established to explore the role of Fas-L on cell growth, apoptosis, and tumour formation in nude mice. Here, we present evidence that down-regulation of endogenous Fas-L in tumour cells not only affects viability of tumour cells but also reduces local immune responses that may consequently modify tumour formation.
MATERIALS AND METHODS

Cells and cell culture condition
Human glioma cell lines U-373MG and U-118MG were purchased from the American Type Culture Collection (Rockville, MD). Transfectants carrying plasmid pEGFP-N1 (vector controls) or Fas-L ribozyme were established in this study. Cells were cultured in Dulbecco modified Eagles' medium (DMEM; Life Technologies, Grand Island, NY) supplemented with 20% fetal calf serum (FCS), 1% penicillin and 1% fungizone at 5%CO 2 /37˚C in a humidified atmosphere. Growth rate was measured by counting viable cell, which was determined by trypan blue exclusion. MTT assay was applied to estimate cellular viability using a commercially available kit (CellTiter 96 ® Aqueous, Promega, Madison, WI). In brief, cells were seeded in 96-well plates (5 × 10 4 cells well -1
), grew for 72 h to confluence, and the WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolumn) was added the last 2 h before the end of culture. The cell-bound dye was measured by optical absorption at 490 nm using a microplate reader.
Construction of Fas-L ribozyme
The sequences of the oligonucleotides used to construct Fas-L ribozyme were as follow: sense sequence: 5′-ATG/AAT/TCC/CGG/AAG/TAC/TGA/TGA/GTC/GTC/ATA/ CGA/ CGA/AAC/TTT/GGA/ TCC/CGA-3′; antisense sequence: 5′-TCG/GGA/TCC/AAA/GTT/TCG/CG/TAT/CAC/GAC/TCA/TCA/ GTA/CTT/CCG/GGA/ATT /CAT-3′. This sequence is corresponding to the coding region in the extracellular domain of Fas-L and does not share homology to other genes according to database search on GenBank, EMBL, PDB and DDBJ. After annealing of these oligonucleotide pairs, the generated fragment was digested with EcoR1 and BamH1, followed by ligation into the EcoR1/BamH1-predigested vector plasmid pEGFP-N1 (Clontech, palo Atto, CA). In this plasmid construct, the ribozyme was directly linked to upstream of the EGFP gene to form a fusion transcript (Figure 1) , so that the Fas-L ribozyme can be monitored indirectly by the expression of EGFP protein. Candidate clone was verified by DNA sequencing.
DNA transfection
Plasmid DNA was delivered into cells using the lipofection method with a ratio of 1 µg DNA /20 µl lipofectamine (Qiagen, Hilden, Germany). Plasmid pEGFP-N1 served as the nonribozyme control. After DNA transfection, cells were grown in regular 20% FCS/DMEM for 48 h, and then selected with geneticin (G418, Sigma, St Louis, MO) at an effective concentration of 0.5 µg ml -1 for at least 3 months before subjected to further study. Stable transfectants derived from U-373MG and U 118MG carrying either Fas-L ribozyme or pEGFP-N1 plasmid were designated as Fas-L ribozyme (U-373MG), Fas-L ribozyme (U-118MG), EGFP(U-373MG) and EGFP(U-118MG), respectively.
Semi-quantitative reversed transcription-polymerase chain reaction (RT-PCR)
Total RNA was purified using the RNeasy Kit followed the manufacturer's instruction (Qiagen) and converted to cDNA by StrataScrip™-H-reverse transcriptase with oligo-dT primer in the presence of RNAsin (Stratagen, La Jolla, CA). RT-PCR for Fas-L, Fas, Bcl-2, FAP-1 and β-actin were performed as described previously (Cleary et al, 1986; Sato et al; Yang et al, 1998) . The generated cDNA was subjected to 35-40 cycles of PCR amplification on a DNA thermal Cycler (Hybaid Omnigene, Middlesex, UK). The existence of ribozyme in stable cells was verified by RT-PCR with primer pair as follow: 5′-TCC/GCT/AGC/GCT/ ACC/GGA/CT-3′ and 5′-GTC/CTT/GAA /GAA/GAT/GGT-3′. This primer pair amplifies a 411 bp from the EGFP/Fas-L ribozyme chimeric transcript spanning upstream of ribozyme into EGFP gene, and a 400 bp DNA fragment from the transcript of authentic EGFP gene. β-Actin served as a quantitative control in PCR. PCR products were fractionated by agarose or NuSieve 3:1 agarose, stained with ethidium bromide, and visualized under UV light.
Western blot
Cells were extracted with a buffer containing 20 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 1 mM PMSF and 0.1 U ml -1 leupeptin. Proteins were separated in SDS-polyacrylamide gel and electroblotted onto polyvinyl difluoride membrane (MSI, Westboro, MO). The proteins bounded on the membrane were probed with mouse antibody (Ab)-recognizing Fas-L (clone33; Transduction Laboratories, Lexington, KY) followed by a sheep anti-mouse IgG conjugated with horseradish peroxidase (Dako Corp, Carpinteria, CA). The Fas-L was made visible by fluorography with enhanced chemiluminescence detection kit (Amersham/Pharmacia Biotech, UK). Duplicate blot was probed with α-tubulin-specific Ab (clone DMIA; NeoMarker, Fremont, CA) and served as a protein-loading control.
Detection of apoptotic cells
Apoptotic cells in 3-day-old culture were stained with merocyanine 540 (MC540, Sigma) according to the published procedures (Reid et al, 1996; Yang et al, 1999) . Apoptotic cells became susceptible to MC540 binding due to alteration of surface membrane and showed FL2 values more than 230 detected by flow cytometry analysis. Apoptotic cells in tumour nodules or liver tissues were detected by TUNEL labelling detecting free 3′-OH groups in fragmented DNA in situ (Apop Tag-peroxidase in situ apoptosis detection kit, Oncor, MD). Paraffin-embedded, slide-mounted tissue sections were deparaffinized, and treated with proteinase K for 15 min followed by 3% H 2 O 2 for 5 min. After nick end labelling with digoxigenin-deoxyuridine triphosphate by deoxynucleotidyl transferase, immunostaining was performed using peroxidase-conjugated antidigoxigenin Ab for 30 min. Apoptotic cells were visualized with diaminobenzidine substrate and became a dark brown colour. Specimen was counterstained with 0.3% methyl green or haematoxylin/eosin.
Tumour formation in nude mice
Male BALB/c-nu mice were purchased from the National Laboratory Animal Breeding and Research Center, Taiwan, ROC and maintained under specific pathogen-free condition. Mice at 8 weeks old were randomly divided into groups and 3-5 mice in a group. Approximate 10 6 stable cells in 0.3 ml PBS were injected subcutaneously into the upper flanks of each mouse. Tumour formation was examined every other day. Injected cells were considered as tumorigenic if tumour nodule with a size more than 3 mm developed at the injection site. Mice were sacrificed one week after tumour nodules were formed. Tumour nodules and liver tissue were surgically obtained, fixed in neutral-buffered formalin, pH 7.2, and then subjected to analyses on tumour-infiltrating cells and apoptotic cells. Infiltrating macrophages and granulocytes were morphologically identified based on the ratio of nuclear to cytoplasm and the presence or absence of granules. EGFP-expressing cells in those tissues were immunostained using rabbit anti-EGFP Ab (Clontech) followed by peroxidase-conjugated goat anti-rabbit IgG Ab (Calbiochem, La Jolla, CA). Sections were counterstained and mounted with glycerol gelatin before examination.
Statistical analysis
Results were analysed by Student's t-test. Differences with P < 0.05 were judged significant.
RESULTS
Fas-L ribozyme plasmid reduced the expression of Fas-L in glioma cells
After growing in geneticin-containing medium for 3 months, more than 90% of stable transfectants carrying either Fas-L ribozyme or pEGFP-N1 plasmid emitted green light under fluorescent microscopy and were morphologically similar to the parental cells. Bulk culture of DNA-transfected cells was used in this study to avoid any bias deduced from cell lines having unwanted gene backgrounds generated during selection. The chimeric transcripts containing Fas-L-specific ribozyme and EGFP sequence were detected in Fas-L (Table 2) . Notably, the infiltrating cells tended to accumulate near the margin of tumour nodules produced by vector controls ( Figure 7B immunostaining on EGFP protein ( Figure 9E, F) . Although all EGFP-positive glioma cells, both Fas-L ribozyme -carrying cells and vector controls, did not form gross detectable tumour nodules in the liver by subcutaneous injection, a few EGFP-positive tumour cells were found among the liver lesions and were morphologically different from those in subcutaneous tumour nodules (comparing Figure 9E) .
DISCUSSION
By using a hammerhead ribozyme we have successfully downregulated the expression of Fas-L in human glioma cells at both mRNA and protein levels. Apoptosis in tumour cells was significantly reduced by Fas-L ribozyme . In nude mice, Fas-L ribozyme -carrying cells formed bigger tumours with significantly fewer infiltrating cells in the tumour areas than vector controls.
Fas/Fas-L signalling has been demonstrated to elicit apoptosis in glioma cells in certain culture conditions (Weller et al, 1994; Shinoura et al, 1998; Yang et al, 1999) . Although cell cycle progression in glioma cells could be promoted by activating Fas antibody (CH-11) probably through the MEK-ERK pathway, however, apoptosis occurred at the same time and the net viable cell count was not increased (Shinohara et al, 2000) . In addition, transfer of Fas-L gene into Renca cells, a Fas signal-sensitive renal cell carcinoma caused a suicidal destruction of tumour cells by apoptosis (Arai et al, 1997 ribozyme caused an increase in growth rate, improved cell viability and speeded up tumour formation indicating that the endogenous tumour Fas-L might not be growth promoting for glioma cells in all. Recently, we had observed that delivering Fas-L ribozyme into murine melanoma or Ras-activated NIH3T3 malignant cell lines also effectively reduced apoptosis in those cells (our unpublished data). It seems that the suicidal effect triggered by Fas-L occur widely in many malignant cells.
The proinflammatory effect of Fas-L has been recognized for days and is attributed partly to local recruitment and activation of neutrophils (Seino et al, 1997; Chen et al, 1998) . Apoptotic body by itself is a potent chemotactic agent for immune cells (Horino et al, 1998) . Besides, when phagocytes engulf apoptotic body, they can effectively initiate T-cell immunity (Chattergoon et al, 2000) . Therefore, the Fas-L ribozyme -associated suppression in tumourinfiltrating cells in nude mice observed in our system could be due to reduced amount of apoptotic body generated by Fas-L ribozyme -carrying cells. Alternatively, Fas/Fas-L engagement between tumour and immune cells in subcutaneous environments will trigger survival favouring signal for cells constituting innate immunity as those cases reported for T cells or tumours (Alderson et al, 1993 , Owen-Shaub et al, 1994 . This possibility waits to be proven by additional study. It is noteworthy that U-373MG, U-118MG and their derivatives tested did not form large tumours in nude mice. It substantiates the effectiveness of the remaining innate immunity in nude mice for tumour control and partly explains the negative correlation between cell infiltration and tumour size in this study. Taken together, Fas-L ribozyme could modify the tumorigenesis of human glioma cells in nude mice by several ways. First, Fas-L ribozyme accelerated tumour cell growth by improving cell viability. Second, Fas-L ribozyme reduced the innate immune reaction against tumour.
The appearance of glioma cells in the liver of tumour-bearing mice was an unexpected finding. Even though tumour nodules were not detected grossly in the liver, EGFP-expressing tumour cells were detectable in this tissue. The glioma cells in liver lesion were with atypical shape, mixed with apoptotic hepatocytes and numerous inflammatory cells indicating rigorous local immune responses. Growth of Fas-L + tumour cells in syngeneic murine host has been shown to induce toxicity in Fas + organs probably through the production of soluble Fas-L (Zeytum et al, 2000) . Hepatocytes are known to express Fas and are very sensitive to Fas-L-mediated cytotoxicity (Ogasawara et al, 1993; Rensing-Ehl et al, 1995) . The expression of Fas-L in human colon cancer has been correlated with the hepatic metastasis and the apoptosis of hepatocytes in tumour lesion (Shiraki et al, 1997) . In our study model, Fas-L ribozyme reduced the severity of liver damage in tumour-bearing mice. Therefore, the killing of hepatocytes in glioma-bearing mice was obviously mediated by a contact with Chi-Mei Foundation Hospital to CC Chio/BC Yang. We are grateful to Drs JC Yu and CC Shieh for critical reading of the manuscript and Miss YF Lu and WY Shieh for technical assistance.
